People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nohla Therapeutics Inc. | — | Biotechnology | Series C | $79.4M | $1.8B | 2015 |
Benjamin Scot Bergo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamin Scot Bergo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Brian Daniels | 1 | 5 |
| Colleen Delaney | 1 | 4 |
| Jim Johnson | 1 | 4 |
| Lawrence Gozlan | 1 | 3 |
| Darren Scotti | 1 | 2 |
| Michael Sistenich | 1 | 2 |
| Kathleen Fanning | 1 | 2 |
| Lawrence David Gozlan | 1 | 1 |
| Gary Christianson | 1 | 1 |
| Darren David Scotti | 1 | 1 |
| Ian David Brown | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.